MedPath
HSA Approval

PICO-SWIFT POWDER FOR ORAL SOLUTION

SIN17163P

PICO-SWIFT POWDER FOR ORAL SOLUTION

PICO-SWIFT POWDER FOR ORAL SOLUTION

January 16, 2025

GOLDPLUS UNIVERSAL PTE LTD

Regulatory Information

HSA regulatory responsibility and product classification details

Regulatory Responsibility

RegistrantGOLDPLUS UNIVERSAL PTE LTD

Product Classification

D
Drug Type
Therapeutic
F
Forensic Class
Prescription Only
HSA Singapore Classification

Formulation Information

POWDER, FOR SOLUTION

ORAL

Medical Information

A06AB58

Manufacturer Information

GOLDPLUS UNIVERSAL PTE LTD

IND-SWIFT LIMITED

Active Ingredients

Citric Acid Anhydrous

12000 mg

Citric acid

Sodium Picosulfate

10 mg

Picosulfuric acid

Magnesium Oxide Heavy

3500mg

Magnesium oxide

Documents

Package Inserts

Package insert.pdf

Approved: January 16, 2025

Download

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.